No results for ‘’
Rajesh Exports Ltd
₹97.51
(5.00%)
Sun, 21 Jun 2026, 09:16 pm
Consumer Durables
Other Consumer Specialties
24.5KRajesh Exports EV/EBITDA Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 17.26 | 18.04 | 10.80 | 8.29 | 18.77 | 12.95 | 9.37 | 8 | 7.37 | 8.85 | 17.14 | 14.38 | 17.13 | 15.22 | 13.28 | 16.72 | 20.20 | 12.56 | 23.06 | 57.81 |
| Price to book ratio | 5.03 | 4.51 | 2.47 | 0.71 | 2.76 | 2.01 | 1.94 | 1.50 | 0.96 | 1.72 | 3.83 | 3.04 | 3.02 | 2.22 | 1.52 | 1.26 | 1.64 | 1.22 | 0.51 | 0.35 |
| Price to sales ratio | 0.22 | 0.28 | 0.27 | 0.06 | 0.20 | 0.16 | 0.15 | 0.12 | 0.09 | 0.11 | 0.11 | 0.07 | 0.12 | 0.11 | 0.08 | 0.05 | 0.08 | 0.05 | 0.03 | 0.01 |
| Price to cash flow ratio | 6.69 | 4.45 | 1.54 | 0 | 7.08 | 6.25 | 0 | 1.42 | 0 | 1.56 | 12.28 | 8.75 | 0 | 6.47 | 6.81 | 0 | 0 | 47.05 | 44.18 | 0.72 |
| Enterprise value | -916Cr | -615Cr | -1801Cr | -2863Cr | -906Cr | -2068Cr | -733Cr | -3497Cr | -1461Cr | -1768Cr | 11351Cr | 8949Cr | 16173Cr | 10929Cr | 4498Cr | 13096Cr | 19395Cr | 16616Cr | 6150Cr | 4664Cr |
| Enterprise value to EBITDA ratio | 0 | -13.07 | -40.48 | 0 | 0 | 0 | -48.70 | 0 | -14.53 | -1.41 | 6.57 | 5.12 | 6.69 | 5.12 | 2.70 | 14.35 | 16.44 | 10.15 | 18.67 | 27.73 |
| Debt to equity ratio | 5.70 | 10.75 | 1.23 | 2.13 | 1.85 | 1.59 | 1.64 | 1.13 | 1.14 | 1.14 | 1.06 | 1 | 1.25 | 0.72 | 0.12 | 0.09 | 0.07 | 0.05 | 0.04 | 0.06 |
| Return on equity % | 34.62 | 37.14 | 37.63 | 10.26 | 18.79 | 18.10 | 23.01 | 20.56 | 13.86 | 21.46 | 26.25 | 23.32 | 19.39 | 16.14 | 12.45 | 7.77 | 8.53 | 10.54 | 2.25 | 0.61 |
Rajesh Exports Ltd Enterprise Value to EBITDA Ratio
The Rajesh Exports Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Rajesh Exports Ltd's valuation, profitability, and overall financial performance. Tracking the Rajesh Exports Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Rajesh Exports Ltd (NSE: RAJESHEXPO, BSE: 531500) is currently trading at ₹97.51, with a market capitalization of ₹2762.16Cr. As a leading company in the Consumer durables sector and Other consumer specialties industry, monitoring the Rajesh Exports Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Rajesh Exports Ltd Enterprise Value to EBITDA Ratio Current Value
The current Rajesh Exports Ltd Enterprise Value to EBITDA Ratio stands at 27.73.
The latest Rajesh Exports Ltd Enterprise Value to EBITDA Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Rajesh Exports Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Rajesh Exports Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 27.73
- 2023: 18.67
- 2022: 10.15
- 2021: 16.44
- 2020: 14.35
The recent rise in Rajesh Exports Ltd Enterprise Value to EBITDA Ratio suggests strengthening valuation trends and improving market sentiment.
What Rajesh Exports Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Rajesh Exports Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Rajesh Exports Ltd.
Rajesh Exports Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Rajesh Exports Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Rajesh Exports Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Rajesh Exports Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.